|
M. Wilming:
Keine Erteilung eines Europäischen Patents vor Ablauf von 18 Monaten ab dem Anmeldetag - zu (Un)Recht?
Download als PDF
epi Information 1/2011, 31-32
Doktorarbeit:
Studies on the Bioactive Form of the Antitubercular
Drug Isoniazid and the Enzymes Involved in its Mechanism of Action
Download als PDF
ETH Lausanne (2002), Publikationsnummer 2633
M. Wilming, A. Iffland, P. Tafelmeyer, C. Arrivoli, C. Saudan, K. Johnsson:
Examining Reactivity and Specificity of Cytochrome c Peroxidase
by Using Combinatorial Mutagenesis
Download als PDF
ChemBiochem (2002), 3(11), 1097-1104
M. Wilming, K. Johnsson:
Inter- and Intramolecular Domain-Interactions of the Catalase-Peroxidase
KatG from M. tuberculosis
Download als PDF
FEBS Lett. (2001), 509(2), 272-6
M. Wilming, K. Johnsson:
Spontaneous Formation of the Bioactive Form of the Tuberculosis Drug
Isoniazid
Download als PDF
Angew. Chem., Int. Ed. (1999), 38(17), 2588-2590
B. Saint-Joanis, H. Souchon, M. Wilming, K. Johnsson, P. Alzari, S. Cole:
Use of Site-Directed Mutagenesis to Probe the Structure, Function
and Isoniazid Activation of the Catalase/Peroxidase, KatG, from Mycobacterium tuberculosis
Download als PDF
Biochem. J. (1999), 338(3), 753-760
|
|
|
|
